MarketPulse

da Vinci system

2 articles
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Medtronic's FDA-Approved Hugo Robot Could Unlock Major Growth as Valuation Gap Widens

Medtronic ($MDT) wins FDA approval for Hugo surgical robot, trading at 27x P/E versus competitor Intuitive Surgical ($ISRG) at 64x, offering potential upside with 2.9% dividend yield.
MDTISRGgrowth opportunityvaluation
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Intuitive Surgical Positioned for Long-Term Growth Despite Near-Term Pressures

Intuitive Surgical faces near-term headwinds but maintains strong long-term growth potential through its dominant robotic surgery platform, structural competitive advantages, and expanding market opportunities.
ISRGtariffscompetitive moat